Cancer results from the disregulation of signaling pathways that control cell growth and cell death. Prostate diseases, including benign prostate hyperplasia and prostate cancer, are the leading malignancies affecting males in the United States and abroad. Factors responsible for the initiation and/or progression of both benign and malignant growth of the prostate remain poorly understood, although androgens and peptide growth factors have been implicated. The novel hypothesis that G proteins contribute to the neoplastic growth and metastasis of the prostate is supported by our recent findings that activation of G protein-coupled receptors for lysophosphatidic acid (LPA) results in increased mitogenic signaling, growth and invasion of cultured prostate cancer cells, and transactivation of the epidermal growth factor and androgen receptors. Further support to this hypothesis is the finding that pertussis toxin, a pharmacologic inhibitor of Gi/o proteins, inhibits the growth and metastasis of prostate cancer PC-3 cells injected into nude mice. Although clearly involved, the mechanisms by which G proteins contribute to growth and metastasis of prostate cancer cells are not known. The central hypothesis of this proposal is that LPA activates a pool of G proteins that mediate the transduction of growth and metastatic signals in prostate cancer cells. Experiments will focus principally on the biochemical and pharmacological properties of LPA-mediated mitogenic signal transduction pathways in prostate cancer cells.
The specific aims are: [1] To determine the effect of LPA stimulation on prostate cell growth and motility using in vitro model systems; [2] To determine the role of specific LPA receptor subtypes in the growth and motility of prostate cells; [3] To identify the specific role of Galpha and Gbetagamma subunits in the LPA- regulated activation of ERK and androgen receptor in prostate cancer cells. The successful conclusion of these proposed studies will provide needed information to rationally develop novel and effective strategies for the control of prostate cancer in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG017952-03
Application #
6614001
Study Section
Special Emphasis Panel (ZRG1-UROL (01))
Program Officer
Bellino, Francis
Project Start
2001-09-01
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
3
Fiscal Year
2003
Total Cost
$231,000
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Bagchi, Gargi; Wu, Juanjuan; French, John et al. (2008) Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells. Cancer Res 68:3225-31
Kelly, Patrick; Moeller, Benjamin J; Juneja, Juhi et al. (2006) The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 103:8173-8
Guo, Rishu; Kasbohm, Elizabeth A; Arora, Puneeta et al. (2006) Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology 147:4883-92
Kelly, Patrick; Stemmle, Laura N; Madden, John F et al. (2006) A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem 281:26483-90
Kasbohm, Elizabeth A; Guo, Rishu; Yowell, Charles W et al. (2005) Androgen receptor activation by G(s) signaling in prostate cancer cells. J Biol Chem 280:11583-9
Cisco, Robin M; Abdel-Wahab, Zeinab; Dannull, Jens et al. (2004) Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4. J Immunol 172:7162-8
Raj, Ganesh V; Sekula, Jeffrey A; Guo, Rishu et al. (2004) Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB. Prostate 61:105-13
Sivashanmugam, Perumal; Tang, Linda; Daaka, Yehia (2004) Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells. J Biol Chem 279:21154-9
Lyons-Darden, T; Daaka, Y (2004) Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells. J Mol Endocrinol 33:165-73
Bookout, Angela L; Finney, Amanda E; Guo, Rishu et al. (2003) Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth. J Biol Chem 278:37569-73

Showing the most recent 10 out of 16 publications